Early Diagnosis of Alzheimer’s Disease Using Subject-Specific Models of FDG-PET Data by Burgos, Ninon et al.
HAL Id: hal-01621383
https://hal.inria.fr/hal-01621383
Submitted on 25 Oct 2017
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Early Diagnosis of Alzheimer’s Disease Using
Subject-Specific Models of FDG-PET Data
Ninon Burgos, Jorge Samper-González, M. Jorge Cardoso, Stanley
Durrleman, Sébastien Ourselin, Olivier Colliot
To cite this version:
Ninon Burgos, Jorge Samper-González, M. Jorge Cardoso, Stanley Durrleman, Sébastien Ourselin, et
al.. Early Diagnosis of Alzheimer’s Disease Using Subject-Specific Models of FDG-PET Data. AAIC
2017 - Alzheimer’s Association International Conference, Jul 2017, London, United Kingdom. pp.1-2,
￿10.1016/j.jalz.2017.06.1618￿. ￿hal-01621383￿
Alzheimer's Association International Conference, Jul 2017, London, United Kingdom. 13 (7), 2017 
http://dx.doi.org/10.1016/j.jalz.2017.06.1618 
	
Early Diagnosis of Alzheimer’s Disease using Subject-specific Models of FDG PET Data 
Ninon Burgos1,2, Jorge Samper-González1,2, M. Jorge Cardoso3,4, Stanley Durrleman1,2, 
Sébastien Ourselin3,4 and Olivier Colliot1,2,5 
 
1 Inria Paris, Aramis project-team, Paris, France 
2 Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, Institut du Cerveau et la Moelle 
épinière (ICM) - Pitié-Salpêtrière Hospital, Boulevard de l’hôpital, Paris, France 
3 Translational Imaging Group, Centre for Medical Image Computing, University College London, 
London, UK 
4 Dementia Research Centre, Institute of Neurology, University College London, London, UK 
5 AP-HP, Departments of Neuroradiology and Neurology, Pitié-Salpêtrière Hospital, Boulevard de 
l’hôpital, Paris, France 
 
Background: In machine learning classification methods developed for dementia studies, 
neuroimaging features, e.g. glucose consumption extracted from PET images, are often used to 
draw the border that differentiates normality from abnormality. However, these features are 
affected by the anatomical variability present in the population, which acts as a confounding factor 
making the task of finding the frontier (i.e. the decision function) between normality and 
abnormality very challenging.  
Methods: To reduce the confounding impact of anatomical variability when trying to distinguish 
disease versus normal ageing, we developed a method able to extract for each individual the signal 
characteristic of abnormality from 18F-FDG PET data. Instead of comparing the patient’s PET 
image to a population of healthy controls as usually done, this framework consists of creating a 
patient-specific model of healthy PET appearance, and comparing the patient’s PET image to the 
model via a Z-score [1]. We applied this method to 321 ADNI2 subjects (89 cognitively normal 
subjects amyloid negative (SUVR < 1.11), and 68 early MCI, 78 late MCI and 86 Alzheimer’s 
disease patients all amyloid positive (SUVR > 1.11)). The subject-specific Z-maps generated with 
the proposed method were then used as features to feed a classification algorithm based on linear 
support vector machines (SVM). We compared the classification results obtained using the subject-
specific Z-maps to the classification results obtained using features directly obtained from the PET 
images, and using state-of-the-art Z-maps. 
Results: The balanced accuracy obtained with the proposed method when differentiating CN from 
early and late MCI (64% and 82%, respectively) was found to be higher than the balanced accuracy 
obtained using PET SUVR values (58% and 75%) and the state-of-the-art Z-maps (64% and 78%) 
as features. More detailed results are shown in Table 1. 
Conclusions: Instead of trying to find the frontier between normality and abnormality at the 
population level, by transporting the problem to the individual level, the proposed method appears 
to offer a more effective way of differentiating dementia stages. 
References: [1] Burgos, N. et al.: Subject-specific models for the analysis of pathological FDG PET 
data. In: MICCAI 2015, pp.651-658 (2015)  
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Figure 1: Examples of FDG PET, state-of-the-art Z-map and proposed subject-specific Z-map 
images for a cognitively normal and an Alzheimer’s disease subject. Note that a negative Z-score 
(red) indicates a reduced FDG uptake in the subject relative to the controls. 
 
 
Table 1: Balanced accuracy obtained when using PET standardised uptake value ratio (SUVR) 
images, state-of-the-art Z-maps (obtained by comparing the patient’s PET image to a population 
of healthy controls), and proposed subject-specific Z-maps (obtained by comparing the patient’s 
PET image to a subject-specific model of healthy PET appearance) as features of the linear SVM 
classification algorithm. 
 CN vs AD CN vs LMCI CN vs EMCI 
PET SUVR images 93% 75% 58% 
State-of-the-art Z-maps 94% 78% 64% 
Proposed subject-specific Z-maps 93% 82% 64% 
CN: cognitively normal – AD: Alzheimer’s disease – LMCI: late mild cognitive impairment – EMCI: 
early mild cognitive impairment 
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Figure	1:	Examples	of	FDG	PET,	state-of-the-art	Z-map	and	proposed	subject-specific	Z-map	images	for	a	cognitively	normal	and	an	Alzheimer’s	
disease	subject.	Note	that	a	negative	Z-score	(red)	indicates	a	reduced	FDG	uptake	in	the	subject	relative	to	the	controls.	
